Catégories
> Physiologie > Transmission par le biais du lait maternel
Transmission par le biais du lait maternel |
Documents disponibles dans cette catégorie (116)
Article : texte imprimé
Davida M. Schiff, Auteur ; Elisha M. Wachman, Auteur ; Barbara Philipp, Auteur |Objectives: Among opioid-exposed newborns, breastfeeding is associated with less severe withdrawal signs, yet breastfeeding rates remain low. We determined the extent to which hospital, maternal, and infant characteristics are associated with br[...]Article : texte imprimé
Edmond D. Shenassa, Auteur ; Xiaozhong Wen, Auteur ; Susan Braid, Auteur |Background: Although the immutable benefits of breastfeeding are well documented, information on the potential consequences of exposure to tobacco metabolites specifically via breastfeeding is sparse. Objective: The aim was to conduct the f[...]Article : texte imprimé
Gillian A. Beauchamp, Auteur ; Robert G. Hendrickson, Auteur ; Daniel A. Spyker, Auteur |Introduction: We described calls to U.S. poison centers (PCs) related to potential exposure to substances through breast milk. Materials and Methods: We analyzed National Poison Data System calls between 2001 and 2017 with Exposure through b[...]Article : texte imprimé
Gastrointestinal Side Effects in the Baby of a Breastfeeding Woman Treated with Low-Dose Fluvoxamine
Faruk Uguz, Auteur |Depression and anxiety disorders are frequently seen in the postpartum period. Primary pharmacological agents for these disorders are antidepressants, especially selective serotonin reuptake inhibitors. Despite no adverse reports, data on safety[...]Article : texte imprimé
Most drugs used to treat IBS are acceptable to use during breastfeeding. Although several medications used in IBS have no information on use in nursing mothers, they appear to pose low risk to the breastfed infant. Dicyclomine and eluxadoline sh[...]Article : texte imprimé
Teresa Baker, Auteur ; Palika Datta, Auteur ; Kathleen Rewers-Felkins, Auteur |Background: Morbidly placenta accreta as a cause of postpartum morbidity is increasing in incidence. One conservative option is use of methotrexate as an adjuvant therapy for the management of placenta accreta. There is concern that use of metho[...]Article : texte imprimé
Molly R. Rabinowitz, Auteur ; Laura R. Kair, Auteur ; Heather L. Sipsma, Auteur |Background: Breastfeeding is fundamental to maternal and child health and is the most cost-effective intervention to reduce child mortality. Pasteurized human donor milk (HDM) is increasingly provided for term newborns requiring temporary supple[...]Article : texte imprimé
Hannah G. Juncker, Auteur ; M. Romijn, Auteur ; Veerle N. Loth, Auteur |Background Human milk contains antibodies against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) following Coronavirus Disease 2019 (COVID-19). These antibodies may serve as protection against COVID-19 in infants. However, the evo[...]NouveautéArticle : texte imprimé
Kelly S. McGlothen, Auteur ; Lisa M. Cleveland, Auteur ; Sara L. Gill, Auteur |Background: Several professional health organizations have made statements endorsing the safety of breastfeeding for women taking medication-assisted treatment for an opioid use disorder. Yet, breastfeeding initiation rates for this population [...]Article : texte imprimé
Karleen Gribble, Auteur ; Kathleen A. Marinelli, Auteur ; Cecilia Tomori, Auteur |Key Messages Some COVID-19 policies separate infants and mothers, preventing or impeding breastfeeding, despite no evidence for vertical transmission of SARS-CoV-2 and generally mild symptoms in infants. Policies separating mothers and infan[...]Article : texte imprimé
Laurence Collin-Lévesque, Auteur ; Yosra El-Ghaddaf, Auteur ; Madeleine Genest, Auteur |Background: Duloxetine and methylphenidate are commonly prescribed for the management of depression and attention-deficit/hyperactivity disorder (ADHD), respectively. However, little information is available concerning their safety during lactat[...]Article : texte imprimé
Güliz Onat, Auteur ; Hediye Karakoc, Auteur |Introduction: Turkey is the first and only Islamic country which has initiated a process to establish a milk bank. However, the effort was abandoned because of religious concerns. Informal breast milk sharing has become a practical alternative t[...]Article : texte imprimé
Objectives: We wanted to investigate whether hyperbilirubinemia (significant or physiological) has an effect on breastfeeding, milk intake, infant's wakefulness, and if any, which level of bilirubin affects breastfeeding. Materials and Method[...]Article : texte imprimé
The LactMed database contains information on drugs to which breastfeeding mothers may be exposed, and the possible adverse effects of those medications in the nursing infant. LactMed is written under contract with the Specialized Information Ser[...]Article : texte imprimé
Constipation is not uncommon in nursing mothers, especially in the immediate postpartum period wherein some constipation is the result of prescribed opioids. A wide variety of products are available to prevent and treat constipation, ranging fro[...]NouveautéArticle : texte imprimé
Hiroaki Aoki, Auteur ; Naoki Ito, Auteur ; Nahoko Kaniwa, Auteur |Objective: Few clinical reports have addressed the use of the antihypertensive drug amlodipine during breastfeeding. The objective of this study is to characterize concentration-time profiles of amlodipine in maternal and infant plasma, and milk[...]Article : texte imprimé
Mourh Jasminder, Auteur ; Hilary Rowe, Auteur |With recent legalization of marijuana in numerous U.S. states, the risk of marijuana exposure via breast milk is a rising concern. This review analyzes the available human and animal literature regarding maternal use of marijuana during lactatio[...]Article : texte imprimé
By last count, 29 U.S. states and the District of Columbia have legalized marijuana (cannabis) for medicinal use.1 More to the point of the concern regarding cannabis use while breastfeeding is the reality that by mid-2017, seven U.S. states and[...]Article : texte imprimé
Roberto Antonucci, Auteur ; Laura Cuzzolin, Auteur ; Alessandra Manconi, Auteur |Background: Usually, no adverse effects are observed in breastfed infants whose mothers are treated with the anti-epileptic carbamazepine. In this article, we described unusual short-term adverse effects observed in a young infant after exposure[...]Article : texte imprimé
Sofia Colaceci, Auteur ; Angela Giusti, Auteur ; Alessia De Angelis, Auteur |Background: In cases of pharmacotherapy, mothers are confronted with the dilemma of breastfeeding and giving up the medication or discontinuing breastfeeding in order to take the drug, thus avoiding any potential risk for the infants. Object[...]Article : texte imprimé
Article : texte imprimé
The conventional model of drug passage into breastmilk states that large molecules such as maternal immunoglobulins can pass into colostrum because spaces between mammary epithelial cells are open. Then, these pores begin to close at the onset o[...]Article : texte imprimé
Overall, several generalizations can be made: (1) most mothers receiving mAbs have unmeasurable or extremely low levels of the mAb in their breast milk; (2) about half of the mAb will be digested in the infant's tract; (3) negligible amounts of [...]Article : texte imprimé
Inger Öhman, Auteur ; Birgitta Norstedt Wikner, Auteur ; Olof Beck, Auteur |This case report describes a woman with narcolepsy treated with racemic amphetamine (rac-amphetamine) during pregnancy and breastfeeding with follow-up on the infants development up to 10 months of age. The pregnancy outcome and the pharmacokin[...]